SOAT2 and obesity disorder: Our study developed PLGA‐b‐PEG and CS coupled Soat2 siRNA nanoparticle system targeting inhibition of intestinal SOAT2 to control dietary fatty acid intake so as to prevent the development of dietary induced obesity.